A Randomized Controlled Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections in Post-menopausal Women

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 55
Maximum Age: 85
Healthy Volunteers: f
View:

• Female, post-menopausal, age ≥ 55 years old

• Diagnosis of recurrent UTI, defined as ≥ 3 symptomatic culture-proven UTI episodes in 12 months or ≥ 2 in 6 months.

• Currently free from a UTI determined based on absence of symptoms as determined by the UTI symptom assessment questionnaire79 and negative urine culture (\<103 colony forming units per ml of urine).

• Able to attend all follow-up appointments for the study.

• A negative upper and lower urinary tract evaluation, including pelvic examination for pelvic organ prolapse (less than stage 2), measurement of post-void residual (less than 50 ml), and imaging (renal ultrasound and standing voiding cystourethrogram) to exclude kidney stone, hydronephrosis, reflux, or urethral diverticulum.

Locations
United States
Texas
University of Texas Southwestern Medical Center
RECRUITING
Dallas
Contact Information
Primary
Jessica de Araujo Paula
jessica.dearaujopaula@utsouthwestern.edu
2146458787
Backup
Meghan Leak
meghan.leak@utsouthwestern.edu
2146458787
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2030-09-30
Participants
Target number of participants: 90
Treatments
Active_comparator: D-mannose
Dietary Supplement: D-Mannose
Placebo_comparator: Placebo
Dietary Supplement: Placebo
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center

This content was sourced from clinicaltrials.gov